Now in the U.S!
With the FDA-approval in hand, Medasense is gearing up to introduce the AI-powered NOL nociception monitoring system at U.S. conferences this fall.
Meet our team and preschedule 1:1 meetings to get answers to all your questions about NOL technology and its clinical benefits in anesthesia.
Enquire about setting up an evaluation at your hospital.